CLINICAL_TRIALS
trial_result
· 2007-10-31
Clinical Trial Update: Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer [NA]
Summary
A completed clinical trial update for Iscar as a second-line treatment for advanced non-small cell lung cancer. The study identifier is NCT00283478.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kentuckiana Cancer Institute | Conditions: Non-Small Cell Lung Cancer | NA | Status: COMPLETED